Difference between revisions of "MEDICATION-ADRENALINE"
From NeuroRehab.wiki
(Imported from text file) |
(Imported from text file) |
||
| Line 1: | Line 1: | ||
1. Naturally occurring catecholamine with <i>alpha </i>(vasoconstriction) & <i>beta </i>effects.<div>2. Administer in the setting of cardiac arrest to cause vasoconstriction and to redirect available CO to the myocardium & brain.</div><div>3. It raises diastolic pressure thereby improving coronoary perfusion and facilitating defibrillation by improving myocardial blood flow during CPR.</div><div>4. Indications: asystole, PEA, pulseless VT/VF, bradycardia unresponsive to atropine.</div><div>5. Given IM in the setting of anaphylaxis: 0.5 mg every 15 min.</div><div>6. SE: tachycardia, HTN, arrhythmias, tissue necrosis if extravasation occurs, hyperglycaemia.</div><div><br></div><div>DOSAGE</div><div>7. Administer 1 mg every second loop of CPR (1:10,000 via IV cannula or 1:1000 via central line).</div><div>8. Infusion of 1-20 mcg/min in ICU.</div> | <div>1. Naturally occurring catecholamine with <i>alpha </i>(vasoconstriction) & <i>beta </i>effects.<div>2. Administer in the setting of cardiac arrest to cause vasoconstriction and to redirect available CO to the myocardium & brain.</div><div>3. It raises diastolic pressure thereby improving coronoary perfusion and facilitating defibrillation by improving myocardial blood flow during CPR.</div><div>4. Indications: asystole, PEA, pulseless VT/VF, bradycardia unresponsive to atropine.</div><div>5. Given IM in the setting of anaphylaxis: 0.5 mg every 15 min.</div><div>6. SE: tachycardia, HTN, arrhythmias, tissue necrosis if extravasation occurs, hyperglycaemia.</div><div><br></div><div>DOSAGE</div><div>7. Administer 1 mg every second loop of CPR (1:10,000 via IV cannula or 1:1000 via central line).</div><div>8. Infusion of 1-20 mcg/min in ICU.</div> | ||
[[Category:Medication]] | [[Category:Medication]] | ||
[[Category:Advanced Life Support]] | [[Category:Advanced Life Support]] | ||
Revision as of 11:50, 15 December 2022
1. Naturally occurring catecholamine with alpha (vasoconstriction) & beta effects.
2. Administer in the setting of cardiac arrest to cause vasoconstriction and to redirect available CO to the myocardium & brain.
3. It raises diastolic pressure thereby improving coronoary perfusion and facilitating defibrillation by improving myocardial blood flow during CPR.
4. Indications: asystole, PEA, pulseless VT/VF, bradycardia unresponsive to atropine.
5. Given IM in the setting of anaphylaxis: 0.5 mg every 15 min.
6. SE: tachycardia, HTN, arrhythmias, tissue necrosis if extravasation occurs, hyperglycaemia.
DOSAGE
7. Administer 1 mg every second loop of CPR (1:10,000 via IV cannula or 1:1000 via central line).
8. Infusion of 1-20 mcg/min in ICU.
